New hot flash drug shows promise in early safety trial
NCT ID NCT02803268
First seen Jan 04, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This early-stage study tested the safety of a new drug called MT-8554 in 24 women who have frequent hot flashes (at least 7 per day). The goal was to see if the drug is safe and how the body processes it. Participants included women with breast cancer or those going through menopause. The study is complete, and results will help decide if further testing is warranted.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASOMOTOR SYMPTOMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational center
City Name, Germany
Conditions
Explore the condition pages connected to this study.